NCT07825766

Brief Summary

Preservation of pelvic autonomic nerves to retain genitourinary function without compromise of oncologic clearance of tumor has been extensively studied in rectal cancer surgery. However, there is still not much information about preservation of autonomic nerves after colectomy for right and left colon cancer. Because the abdominal deep-seated neural structures, such as abdominal plexus (superior hypogastric plexus), neurovascular bundles of SMA, SMV and IMV were within the boundary of dissection, traditional colectomy for right and left colon cancer extended simultaneous dissection of the lateral bundles and entire circle of the neural plexuses surrounding the SMV and IMV. However, a severe and persistent diarrhea, enterospasm, or enteroparalysis developed in almost some patients. It is therefore opinion that during the colectomy for right and left colon cancer, preservation of autonomic nerves may be a priority-that is, autonomic nerve preservation is appropriate unless there are oncologic reasons for the resection of nerves. Therefore, the investigators conducted the present study to test the feasibility of laparoscopic approach in performing the total abdominal autonomic nerve preservation during the standard oncologic resection of right/left colon cancer. The investigators hypothesized that given a well-illuminated magnified view by laparoscopy, the autonomic nerves can be well protected from inadvertent surgical damage. Therefore, the investigators aimed to compare the efficacy and safety of the total abdominal autonomic nerve preservation (TNP) versus traditional CME of right/left colon cancer.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
23mo left

Started Jul 2026

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress12%
Jul 2026Sep 2028

Study Start

First participant enrolled

July 1, 2026

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

September 7, 2026

Completed
10 days until next milestone

First Posted

Study publicly available on registry

September 17, 2026

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2027

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2028

Last Updated

September 17, 2026

Status Verified

August 1, 2026

Enrollment Period

1.2 years

First QC Date

September 7, 2026

Last Update Submit

September 11, 2026

Conditions

Outcome Measures

Primary Outcomes (3)

  • defecation frequency

    defecation frequency

    one year

  • diarrhea

    diarrhea frequency

    1 year

  • enterospasm

    enterospasm frequency

    1 year

Secondary Outcomes (1)

  • oncological outcome

    3-year

Other Outcomes (1)

  • surgical complications

    30 days

Study Arms (2)

TNP :Abdominal autonomic nerve were preseverd in the colectomy for right and left colon cancer

Abdominal autonomic nerve were preseverd in the colectomy for right and left colon cancer

Procedure: Abdominal autonomic nerve preserverd in the TNP arm

traditional CME

Abdominal autonomic nerve were dissected in the CME

Interventions

Abdominal autonomic nerve is preserverd in colectomy for right and left colon cancer.

TNP :Abdominal autonomic nerve were preseverd in the colectomy for right and left colon cancer

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Pathologically confirmed adenocarcinoma of right side of colon and descending colon.

You may qualify if:

  • years old
  • Pathologically confirmed adenocarcinoma of right side of colon and descending colon.
  • Localization of the tumor ranging from the cecum to the descending colon
  • Tumors clinically staged as T2-4aN0M0 or TanyN + M0, according to imaging studies including enhanced computed tomography (CT) scan, magnetic resonance imaging (MRI), etc.
  • American Society of Anesthesiologists (ASA) score of I, II, or III.

You may not qualify if:

  • Synchronous or metachronous multiple primary colorectal cancer
  • Preoperative imaging examination shows enlargement of the central lymph nodes, which mandates a D3 lymphadenectomy
  • Preoperative imaging examination shows that the tumor involves the adjacent organs, requiring combined multiple organ resections, or radical excision (R0 resection) is not possible
  • History of any other malignant tumor in past 5 years, except for cervical carcinoma in situ that has been cured, basal cell carcinoma, or squamous cell carcinoma of skin
  • Patients who need an emergency operation
  • Patients who are not suitable to undergo laparoscopic surgery (due to, e.g., extensive adhesion caused by prior abdominal surgery, inability to endure artificial pneumoperitoneum, etc.).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fudan University Shanghai Cancer Center

Shanghai, Shanghai Municipality, 200030, China

Location

MeSH Terms

Conditions

Colonic Neoplasms

Condition Hierarchy (Ancestors)

Colorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal Diseases

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Target Duration
3 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

September 7, 2026

First Posted

September 17, 2026

Study Start

July 1, 2026

Primary Completion (Estimated)

September 1, 2027

Study Completion (Estimated)

September 1, 2028

Last Updated

September 17, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will share

baseline data

Shared Documents
STUDY PROTOCOL

Locations